Skip to content

Clinical trials

Multiple Endocrine Neoplasia Type 1 trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Phase: Not applicable Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20061
20072
20082
20094
20107
20118
20123
20144
20156
20162
20175
20187
20194
20208
202111
20224
20236
20245
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Unknown status14
Active, not recruiting6
Recruiting3
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Hospital for Sick Children6
Arizona State University4
P.L.Shupik National Medical Academy of Post-Graduate Education3
University of California, Los Angeles3
Florida State University2
Islamic Azad University, Sanandaj2
Laval University2
State University of New York - Downstate Medical Center2
University of California, San Diego2
University of Pennsylvania2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 1100
Obesity15
Overweight10
Weight Loss9
Acquired Immunodeficiency Syndrome7
HIV Infections5
Cardiovascular Diseases4
Osteoporosis4
Diabetes Mellitus, Type 23
Insulin Resistance3

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.